Sanofi to enroll thousands for its coronavirus vaccine trialsSanofi is working on two vaccine projects to prevent COVID-19 - the illness caused by the new coronavirus - and said it is exploring severa...
Biocon links with Mexico's PiSA to tap US insulin marketBiocon said it has entered into a co-development and commercialization alliance with PiSA of Mexico for recombinant human insulin aimed at ...
Glaxo considering all options against CCI orderSlapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals today said it would review the or...
Government nod to 15 FDI plans; CCEA to consider HDFC proposalThe proposals were cleared by Foreign Investment Promotion Board (FIPB) headed by the Economic Affairs Secretary in its meeting held earlie...
Elder Pharma down on profit-booking post stake sale rumoursThe stock had rallied over 13 per cent on Thursday on rumours that Sanofi SA’s Indian arm was close to buy out Elder Pharma’s domestic form...
Superior packaging can’t be used to raise prices: High Court to Sanofi SAEarlier, dismissing the argument, the National Pharmaceutical Pricing Authority asked the company to reduce the price immediately.
Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.
- Vodafone tax verdict will have effect on similar cases: Finance ministry
The Supreme Court's judgement in Vodafone tax case will have its effect on many similar cases, the Parliament was informed today.
- Glenmark gets $25 mn from Sanofi as final upfront payment
Glenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...
- Glenmark receives $25 mn from Sanofi as upfront payment
Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...
- Dr Reddy's launches Fexofenadine HCl in US
Dr Reddy's Laboratories today announced the launch of generic version of Allegra -- Fexofenadine HCl -- tablets in the US market.
- Genzyme board rejects Sanofi $69-a-share offer
Biotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pact
Shares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...
- US court bans Sun from selling Eloxatin: Sanofi Aventis
French drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Sanofi-Aventis to buy Chattem for $1.9 bn
French drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
- Zentiva recommends shareholders reject Sanofi Aventis' bid
The board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
- Sanofi, Abbott file lawsuit against Glenmark
Sanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hype...